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Prognostic Importance of Exercise Brain atriuretic Peptide in
Asymptomatic Degenerative Mitral Regurgitation
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Background: Exercise Doppler echocardiographic stress test can be of
interest in the management of asymptomatic patients with primary MR. The
resting BNP level is a good surrogate marker of MR consequences and is a
powerful predictor of outcome. The incremental prognostic value of BNP
response during exercise is unknown. We aimed to identify the determinants
of exercise brain natriuretic peptide (BNP) level and to evaluate its prognostic
value in asymptomatic patients with primary mitral regurgitation (MR).
Methods: Comprehensive resting and exercise transthoracic Doppler-
echocardiography was performed in 113 consecutive asymptomatic patients
with moderate to severe degenerative MR and preserved LV function. Blood
samples were collected both at rest and exercise.
Results: The BNP level significantly increased from rest to exercise
(p<0.0001). The independent determinants of exercise BNP were resting E/Ea
ratio (p=0.043), indexed left atrial volume (p=0.022) and exercise LV global
longitudinal strain (p=0.001). There was a significant graded relationship
between increasing BNP level at exercise (according to tertiles) and increased
incidence of cardiac events (death, heart failure, mitral valve surgery driven
by symptoms or LV dilatation/dysfunction onset) (2-year: 21±7 vs. 40±8 vs.
67±9%; in tertiles 1, 2 and 3, respectively). On multivariable analysis, after
adjustment for demographic and echocardiographic data and for resting BNP
level, exercise BNP remained significantly associated with increased risk of
cardiac events during the follow-up (hazard ratio= 2.8 and 3.4, p=0.041 and
0.023, for tertiles 2 and 3, as compared to tertile 1).
Conclusions: In asymptomatic patients with primary regurgitation, exer-
cise BNP level provides important incremental prognostic value beyond what
is achieved by demographic and echocardiographic data and resting BNP
level. Patients with elevated exercise BNP should be considered at high risk
of reduced cardiac event-free survival.
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Quantification of mitral regurgitation by calculation of regurgitant
volume: 3D left ventricular echocardiography versus PISA
Florence Arsac, Nicolas Floris, Patricia Reant, Marina Dijos, Raymond
Roudaut, Stéphane Lafitte
Hôpital cardiologique de Haut lévèque, Pessac, France
Quantification of mitral regurgitation (MR) by echocardiography is well
established using several echo or Doppler parameters in which effective regur-
gitation office area (ERO) and regurgitant volume (RV) are the most com-
monly used. However, hemispheric assumptions allowing application of
proximal isovelocity area (PISA) may be erroneous due to complex mitral
valve morphology (i.e. mitral valve prolapse).
We hypothesized that 3D left ventricular echocardiography associated with
pulse Doppler could obtain RV with high reliability for comparison of 2
methods (3D vs PISA) in presence of mitral regurgitation.
Methods: First, in 50 patients without MR, we compared LV ejection vol-
umes (LVEj) from a full volume 3D echocardiographic acquisition and 2D Sim-
pson method to the aortic stroke volume (ASV) obtained by Pulsed Doppler for
validation of the 3D approach. Second, we analyzed 50 patients with different
degree MR for comparison of the two approaches and verification of PISA RV
values. Inter and intra observer variabilities were assessed for all techniques.
Results: Correlations and Bland&Altman methods gave high adequacy
between 3D LVEj and ASV compared to 2D and ASV (respectively 3D,
r=0.96, y=0.91x+4.8, mean error (ME) and 95% confidence interval of error
(CIE) [-0.84±6 ml] and 2D, r=0.81, y=0.78x+5.8, [-5.41±16 ml]. Variabilities
average for 3D LVEj was 6±3% and 15+/-5% for 2D. In patients with mitral
regurgitation, RV from PISA and 3D LVEj were 23.1±12 ml and 24.5±11 ml
(p=0.37) and the fractional regurgitation 32±13% and 33±12% (p=0.63).
However, mean error measurement was –1.37 ml and 95% confidence interval
of error was 17.90 ml showing high discrepancy between the two methods. By
selecting a cut-off of 5, 10, 15 ml, numbers of patients with uncorrected mea-
surements was 48.5, 17 and 8.5%. When using ASE 4 grades classification,
25,7% of misclassified patients was obtained with PISA.
Conclusion: 3D LVEj method is robust and reliable for calculation of
mitral regurgitant volumes with significant differences compared than those
obtained with PISA which seems to be less adequate for all types of MR.
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Objectives: Pevalence, determinants and prognosis value of right ventricular
(RV) ejection fraction (EF) in organic mitral regurgitation (MR).
Methods: Two-hundred eight pts (62±13 years, 138 males, AF 57 pts)
with organic MR referred to surgery underwent an echocardiography and left
ventricular (LV) and RV radionuclide angiography. LV and RV regional func-
tion was assessed.
Results: Mean RV EF was 40.7±10.1%, ranging from 10 to 65%. Sixty pts
(29%) had a RV EF ≤35%. In multivariate analysis, LV septal function (LV
EF 8: β=0.56, P<0.0001; LV EF 9: β=0.22, P=0.046), LV EDD index (β=–0.27,
P<0.0001) and PASP (r=–0.19, P=0.008) were predictors of RVEF. In the
subgroup with MR quantitation (n=85) predictor of RV EF was mitral ERO
(β=–0.30, P=0.007). After surgery, RV EF increased strongly (27.5±4.3 to
37.9±7.3, P<0.0001) in pts with preoperative RV EF ≤35% while it did not
change in pts with RV EF>35% (46.0±6.9 to 46.1±8.2, P=0.91). Independent
predictors of postoperative RV EF were preoperative RV EF (β=0.32,
P=0.013) and TR ≥grade 2 (β=–0.22, P=0.036) while LV septal function (LV
EF 8, β=0.24, P=0.069) was marginally predictive. Fifty-seven pts died during
post-operative follow-up of 7.1±4.3 years. Pts with RV EF ≤35% compared
with RVEF>35% had a similar survival rate at 10 years (63.6±8.7% versus
68.8±5.3%, P=0.68), but cardiovascular mortality was higher (25.3±8.0%
versus 8.1±3.5%, P=0.03; HR=2.67, 95% CI 1.06-6.76, P=0.037). RV EF was
not a predictive factor of operative mortality. In a Cox model, NYHA class,
CABG, and left atrial diameter, but not RV EF, were independent predictors
of overall mortality.
Conclusion: In organic MR RV function depends not only on PASP but
mainly on LV remodeling and septal function, and improves strongly after
surgery. RV EF is a predictor of cardiovascular mortality in univariate but not
in multivariate analysis. Hence, impaired RV EF before surgery is not a suffi-
cient argument to deny surgery in patients with organic MR.
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Background: Modalities (undersizing annuloplasty – UA- vs mitral valve
replacement – MVR-) and outcome of surgical treatment of functional mitral
regurgitation (FMR) are still debated.
Objectives: Early and mid-term outcome of patients operated for symp-
tomatic severe FMR; Comparison of respective results of UA and MVR.
Methods: Inclusion criteria: Severe FMR due to either ischemic or non
ischemic cardiac disease; Heart failure symptoms despite optimal medical
treatment; LVEF<40%.Primary endpoints: In-hospital mortality; Late CV
mortality Secondary endpoints: Evolution of LVEF after surgery; Recur-
rence of MR.
Results: 59 consecutive patients included between 1997 and 2011, mean
age=65±10,i schemic disease in 41 (70%),heart failure symptoms in all,
LVEF= 36±6%,ERO=41±17 mm².Surgical procedures included 12UA and
47 MVR with only 8 (13%)concomitant CABG. MVR and UA groups were
comparable for age, ischemic etiology, LVEF, ERO and sPAP (all p>0.5).In-
hospital mortality: 3.3% overall, 8.3% in UA group and 2.1% in MVR group
(p=0,36).Eight-year survival free from CV death: 58±13% in the total
population, 60±18% in the UA group and 72±10% in the MVR group
(p=0.48). By multivariable analysis, older age (1.22 [1,05-1,42], p=0,008) and
LV end-diastolic diameter (1.25 [1.05-1.49], p=0,01) independently predicted
late mortality with borderline effect of pre-op LVEF (1.1[0.99-1.2], p=0,08)
whereas type of surgery did not (1.7 [0,38-7.55], p=0.48). LVEF did not
change between pre-op and late FU echo in the MVR group (36±6% vs
36±10%, p=0.68) but tended to decrease in the UA group (37±5.8% vs
31±12%, p=0.1). In the UA group, 50% of patients experienced recurrence of
significant MR (mean post-op ERO=19±4 mm²) whereas no patients in the
MVR group presented with post-op MR.
Conclusions: Despite severe clinical and echocardiographic presentation,
surgical treatment of FMR can be performed with an acceptable operative risk
and mid-term survival. MVR is a reasonable approach, which does not expose
patients to MR recurrence, particularly frequent after UA.
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Minimally invasive approach for mitral valve surgery, as safe and as
reliable than sternotomy. Does it should be the standard approach?
Experience in 368 patients
Vincent Doisy, Marc Vigneron, Fabrice Wautot, Jean-Philippe Frieh,
Nicolas Chavanis, Alain Curtil
Clinique du Tonkin, Villleurbanne, France
To assess the reliability of minimally invasive approach, as this approach
is contest in France we review part of our experience in one center.
Methods: From January 2009 to April 2012, 368 patients were operated of
isolated mitral surgery in a single center. In a retrospective study we analyze
follow-up with focus on surgical approach to emphasize on the safety of min-
imally invasive strategy.
During that period video-assisted procedure was perform for 222 patients
and 146 underwent standard sternotomy.
Results: Results on different parameters are analyzed, we report no dif-
ference in mortality, in-hospital stay length, stroke, bleeding, use of cate-
cholamine between the two groups. Cross clamping, ECC times were longer
in minimally invasive group. ICU time was longer in standard sternotomy
group. In terms of results in efficiency upon plasty results, results were
better in the minimally invasive group with 90,4% success of plasty when
planned.
All parameters are detailed in the study.
Reliability of the procedure is modulated by experience of surgeon, two
surgeons are mainly involved in minimally invasive program, they are more
experienced in mitral plasty so that explain good repair vs replacement rate in
this group.
Conclusion: On the basis of this retrospective study we conclude than
minimally invasive approach is as safe as standard approach for mitral surgery
and as reliable on repair rate in mitral regurgitation.
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Background: The aim of this study is to assess the impact of preoperative
AF on outcome in patients undergoing MVR for mitral valve prolapse (MVP).
Methods: Between 1991 and 2009, 348 consecutive patients underwent
MVR for MR due to MVP (follow-up: mean duration 105±50 months).
Echocardiography was performed preoperatively and 9 to 12 months after sur-
gery. Post operative left ventricular dysfunction (LVD) was defined as ejec-
tion fraction (EF) < 50%. Results: There were 81 patients (23.3%) in AF at
baseline. Preoperative EF decreased from 67.2±9.6% to 58.9±10.1% post
operatively (p< 0.0001). Patients in AF were older (70±9 vs. 64±11 years,
p<0.0001), more often in NYHA III – IV class (p=0.028), had a significantly
higher EuroSCORE (4.4±5.7 vs. 2.8±2.4, p<0.0001). At baseline, patients in
AF had a lower preoperative EF (64±11 vs. 68±9%, p=0.001). Early mortality
was 4.9% in patients with preoperative AF vs. 1.9% in sinus rhythm (n=5,
p=0.13). Multivariate analysis did not identify AF as a predictor of early mor-
tality whereas EuroSCORE (p =0.001) and low pre-operative EF (p=0.001)
were independent risk factors for early mortality. On multivariate analysis
adjusted for EuroSCORE, NYHA III – IV class and preoperative LVEF, pre-
operative AF was identified as an independent predictors of overall mortality
(OR 1.9; p=0.03) and of occurrence of heart failure (OR 2.2, p=0.054). After
adjustment for gender, EuroSCORE, NYHA III-IV class and preoperative EF,
preoperative AF and pre-operative EF were the 2 predictors of post-operative
LVD (OR 2.2 p=0.025 and OR 1.04, p=0.03 respectively).
Conclusion: Preoperative AF is an independent predictor of long term
mortality and post-operative LVD after MVR for MPV.
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What are long-term results of percutaneous mitral commissurotomy
in patients with few or no symptoms?
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Purpose: Percutaneous mitral commissurotomy (PMC) has enabled
patients (pts) to be treated at an earlier stage of their disease than by surgery.
However, very long-term results have not been specifically studied in this
context.
Methods: From 1986 to 1995, 237 patients in NYHA class I or II under-
went PMC in our department. Mean age was 46±12 years; 74 patients (31%)
had atrial fibrillation and 22 (9%) had a history of commissurotomy. Most
patients were in NYHA class II (232 pts, 98%). As assessed by echocardio-
graphy, mean valve area was 1.1±0.2 cm² (≤1.5 cm² in all cases); 40 patients
(17%) had pliable valves and mild subvalvular disease, 145 (61%) had severe
subvalvular disease, and 52 (22%) had calcified valves. PMC used a single-
balloon in 5 pts, a double-balloon in 93 and the Inoue balloon in 139.
Results: After PMC, valve area increased to 1.9±0.3 cm² as assessed by
2D echo. Severe mitral regurgitation (grade ≥3/4) occurred in 4 patients
(1.7%). There were no other severe immediate complications. Good imme-
diate results (valve area ≥1.5 cm² without mitral regurgitation >2/4) were
obtained in 223 patients (94%). The 20-year actuarial rate of survival without
surgery or repeat PMC and in NYHA class I or II was 41±4% in the whole
population.
After good immediate results, the 20-year rate of good functional results
was 42±3%. A Cox multivariate model identified 2 predictors of good late
functional results after good immediate results: young age (p=0.05) and a
large valve area after PMC (p=0.002). In the 142 patients aged ≤50 years, the
20-rate of good functional results was 50±6%.
